Delivery Order SPE2DE21D0005-SPE2D625F83GA

Award Date 2/18/25
Potential Completion Date 2/21/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for APLIGRAF, a skin substitute product. The contract has no set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
This federal contract award, with ID SPE2DE21D0005|SPE2D625F31DY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products headquartered in Canton, Massachusetts. The $1,239.95 delivery order is for the supply of APLIGRAF, a skin substitute product, and does not utilize any set-aside designation. Organogenesis is an established vendor for the DLA and the Department of Veterans Affairs (VA), providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. Organogenesis, a for-profit manufacturer, has an established track record of supplying specialized medical supplies, including wound care and tissue regeneration solutions, to the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
This federal contract award to Organogenesis Inc., a regenerative medicine company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, an advanced wound care product, to support military medical needs. The contract has a ceiling value of $1,239.95 and runs through December 17, 2024. While the award does not utilize a set-aside designation, Organogenesis has been the recipient of prior contracts through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order, valued at $1,239.95, is for the company's APLIGRAF skin substitute product. The order is a fixed-price contract with economic price adjustment, and does not utilize a set-aside designation. Organogenesis Inc. is a long-standing federal contractor, providing a range of wound care and surgical biologics to the...
This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a tissue regeneration product. The $1,239.95 fixed-price with economic price adjustment contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of September 25, 2024. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award...
This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a wound care product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order, which includes an economic price adjustment, has a completion date of June 11, 2024. Organogenesis Inc. is a for-profit manufacturer of goods and has been a registered federal contractor since 2006. The company holds several significant Indefinite...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F83GA
    Delivery Order

This federal contract award, with ID SPE2DE21D0005|SPE2D625F83GA, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer and provider of regenerative medical products. The $1,239.95 fixed-price delivery order contract is for the supply of APLIGRAF, a skin substitute product, to support advanced wound care and tissue regeneration needs across military and veteran healthcare systems.

Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, totaling over $100 million, that enable the company to provide a comprehensive range of regenerative medicine products. This particular award was not designated as a set-aside contract, indicating Organogenesis competed as a standard commercial vendor. The contract has an ultimate completion date of February 21, 2025.

Generated 5/20/25, 1:58 PM